Robitussin and Dimetapp have both been voluntarily recalled by the manufacturer, Glaxosmithkline, due to potential overdose risks.

As of the date of the recall announcement, GSK said they did not know of any overdose incident and had not nay consumer complaints regarding the incorrect dosing cups.

Consumers with questions regarding about this recall or to report an adverse experience should call 1-800-762-4675, during regular business hors.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Regular Mail or Fax: Download the form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178